2021
DOI: 10.1080/14647273.2021.1922764
|View full text |Cite
|
Sign up to set email alerts
|

Genetic andin silicoanalysis show a role ofSMAD3on recurrent pregnancy loss

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 38 publications
0
5
0
Order By: Relevance
“…TGF-βs-through activation of downstream signaling mediators-and SMAD2/3 are triggering factors for preeclampsia, resulting in abnormal placental development [86,87]. SMAD3 is further involved in key gestational processes, immune regulation, and inflammation and its altered expression may be associated with recurrent pregnancy loss [88] and preterm birth [89]. Accordingly, our gestational adenomyosis organoids (imitating early pregnancy) showed increased levels of TGF-β2 and SMAD3, recapitulating adenomyosis tissue characteristics.…”
Section: Discussionmentioning
confidence: 71%
“…TGF-βs-through activation of downstream signaling mediators-and SMAD2/3 are triggering factors for preeclampsia, resulting in abnormal placental development [86,87]. SMAD3 is further involved in key gestational processes, immune regulation, and inflammation and its altered expression may be associated with recurrent pregnancy loss [88] and preterm birth [89]. Accordingly, our gestational adenomyosis organoids (imitating early pregnancy) showed increased levels of TGF-β2 and SMAD3, recapitulating adenomyosis tissue characteristics.…”
Section: Discussionmentioning
confidence: 71%
“…Research has demonstrated that SNPs at the Smad3 gene locus are associated with RPL. Abnormal expression of the Smad3 gene can disrupt steroid hormone regulation and embryo implantation processes by impacting the Smad3-dependent signaling pathway, ultimately resulting in PL [ 65 ]. Likewise, bioinformatics investigation reveals that SMAD 3 is one of the central genes implicated in the onset of GDM [ 66 ].…”
Section: Discussionmentioning
confidence: 99%
“…Several studies have shown a possible association between polymorphisms in TGF-β1, TGF-β2, and TGF-β signaling pathway genes and susceptibility to many diseases. [18][19][20][21] Many genetic studies on TGF-β signaling pathway gene polymorphisms also suggest their possible involvement in the pathogenesis of URSA, [22][23][24] however, these reports are controversial and inconclusive. In the present study, we screened 7 related gene loci on the TGF-β signaling pathway for study, and the results showed that the IL-6 gene -174G/C locus (rs1800795) and the TGF-β1 gene -509T/C locus (rs1800469) had significant differences in genotype and allele distribution frequencies between the case and control groups, and presumably their genetic polymorphisms may be associated with URSA.…”
Section: Discussionmentioning
confidence: 99%
“…[ 70 ] Bremm conducted a case-control study of 149 women with URSA and 159 control women and found that the C allele of the C.207-19370T > C (rs17293443) locus of the Smad3 gene was less frequent in the case group than in the control group and that CC and CT genotypes were associated with a lower risk of URSA, demonstrating that Smad3 gene polymorphisms may influence URSA susceptibility. [ 24 ]…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation